LifePoint, Inc. (LFPI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2004 | 7.42 Million USD | -48.51% |
| 2003 | 14.41 Million USD | 17.25% |
| 2002 | 12.29 Million USD | 62.06% |
| 2001 | 7.58 Million USD | 86.61% |
| 2000 | 4.06 Million USD | 48.21% |
| 1999 | 2.74 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2005 Q3 | 1.51 Million USD | 8.11% |
| 2005 Q1 | 1.36 Million USD | -51.22% |
| 2005 Q2 | 1.4 Million USD | 2.56% |
| 2004 FY | 7.42 Million USD | -48.51% |
| 2004 Q4 | 2.8 Million USD | 56.19% |
| 2004 Q3 | 1.79 Million USD | 68.82% |
| 2004 Q2 | 1.06 Million USD | -39.31% |
| 2004 Q1 | 1.74 Million USD | -68.23% |
| 2003 Q2 | 3.32 Million USD | 12.01% |
| 2003 Q4 | 5.5 Million USD | 111.04% |
| 2003 Q1 | 2.97 Million USD | -16.15% |
| 2003 Q3 | 2.6 Million USD | -21.61% |
| 2003 FY | 14.41 Million USD | 17.25% |
| 2002 Q4 | 3.54 Million USD | 14.55% |
| 2002 Q3 | 3.09 Million USD | -1.99% |
| 2002 Q1 | 2.49 Million USD | 7.52% |
| 2002 Q2 | 3.15 Million USD | 26.33% |
| 2002 FY | 12.29 Million USD | 62.06% |
| 2001 FY | 7.58 Million USD | 86.61% |
| 2001 Q4 | 2.32 Million USD | 21.39% |
| 2001 Q3 | 1.91 Million USD | 9.16% |
| 2001 Q2 | 1.75 Million USD | 10.11% |
| 2001 Q1 | 1.59 Million USD | 23.41% |
| 2000 Q1 | 807.93 Thousand USD | 0.0% |
| 2000 Q2 | 971.3 Thousand USD | 20.22% |
| 2000 Q3 | 995.63 Thousand USD | 2.51% |
| 2000 Q4 | 1.29 Million USD | 29.67% |
| 2000 FY | 4.06 Million USD | 48.21% |
| 1999 FY | 2.74 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -159.274% |
| Ansell Limited | 495.5 Million USD | 98.502% |
| Ansell Limited | 495.5 Million USD | 98.502% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | 91.034% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -328.938% |
| Psykey, Inc. | 1.21 Million USD | -511.783% |
| ConvaTec Group Plc | 910.31 Million USD | 99.184% |
| ConvaTec Group Plc | 872.5 Million USD | 99.149% |
| Encision Inc. | 3.77 Million USD | -96.568% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -5135.045% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -6653.209% |
| Innovative MedTech Inc. | 6.09 Million USD | -21.723% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -16.93% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -768.289% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -922.383% |
| Reflect Scientific, Inc. | 1.06 Million USD | -597.93% |
| SmileDirectClub, Inc. | 517 Million USD | 98.564% |
| Sector 10, Inc. | 39.84 Thousand USD | -18532.341% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.888% |
| SheerVision, Inc. | 2.33 Million USD | -218.398% |
| United Health Products, Inc. | 2.42 Million USD | -205.945% |
| Vasamed, Inc. | 4.67 Million USD | -58.87% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -189.791% |
| Yubo International Biotech Limited | 1.25 Million USD | -490.191% |